Merck Sharp & Dohme LLC – FDA 483, Aug 23, 2024
An FDA inspection of Merck Sharp & Dohme LLC in West Point, PA, revealed significant deficiencies across three observations. The firm failed to thoroughly investigate various discrepancies, including foreign material contamination and numerous HEPA filter failures, and lacked adequate procedures to prevent microbiological contamination of sterile drug products. Additionally, equipment cleaning and maintenance practices were found to be insufficient, potentially impacting the quality and purity of several biological drug products.
ID · 1dea200c-704e-401b-9776-f1543cb04387
- EIR - 2019-09-20
- 483 - 2019-09-09
- 483 - 2019-04-30
- 483 - 2015-04-17
- 483
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.